Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes

Jessamy Tiffen(University of Sydney), Peter Hersey(Royal Prince Alfred Hospital)
Oncotarget
August 12, 2015
Cited by 83


Related Papers